Investing Profile

Ivan Gergel

InvestorVC
Managing Partner and Chief Medical Officer at New Rhein Healthcare Investors
Photo of Ivan Gergel, Managing Partner at New Rhein Healthcare Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
The Wharton School Network
429 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
$47.7M
CompanyStageDateRound SizeTotal Raised
Corsair Pharma
Series BSep 2023$23M
$23M
President R&D Forest Laboratories (now Allergan)Present
Chief Scientific Officer HotmailPresent
Director Board of Directors CoriumPresent
Head of Development & Chief Medical Officer Nektar TherapeuticsPresent
Director Board of Directors Realm Therapeutics, Inc.Present
Director Board of Directors TAO Synergies Inc.Present
Director Board of Directors Neuraptive Therapeutics, Inc.Present
Director Board of Directors HotmailPresent
Director Board of Directors TheranicaPresent
Chairman of the Board of Directors Corsair PharmaPresent
Managing Partner and Chief Medical Officer New Rhein Healthcare InvestorsPresent
Royal College of Psychiatrists MRCPsych Psychiatry
The Wharton School Master of Business Administration - MBA Business Administration and Management, General